Lymph Node Ratio Is a Reliable Prognostic Marker after Neoadjuvant Therapy and Pancreaticoduodenectomy for Pancreatic Cancer, but Does Not Predict the Utility of Adjuvant Therapy. (2022) - Adams, A.